More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.
Jerry Cacciotti
Advertisement
Articles by Jerry Cacciotti
Pharmaceutical Executive
The disease profiles pharma companies pursue should shape the business models that enable them to grow.
Advertisement
Latest Updated Articles
Pharm Exec 50: Growth from the Bottom UpMay 1st 2012
Pharma's Next Top Model: Slimmer Business ModelsMarch 1st 2006
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5